Document is current
Any future updates will be listed below
-
Authors
Yamanaka, Taro
Ukita, Jumpei
Xue, Dongyi
Kondoh, Chihiro
Honda, Seiwa
Noguchi, Maiko
Yonejima, Yoshiko
Nonogaki, Kiyomi
Takemura, Kohji
Kizawa, Rika
Yamaguchi, Takeshi
Tanabe, Yuko
Suyama, Koichi
Ogaki, Keisuke
Miura, Yuji
- License Information
-
More Information
Article History
Received: 20 May 2024
Accepted: 6 March 2025
First Online: 21 March 2025
Competing interests
: M3 AI, Inc. is subsidiaries of M3, Inc. J.U., D.X., S.H., and K.O. are employees of M3, Inc. J.U., S.H. and K.O. hold stock in M3, Inc. M.N. is an employee of Mebix, Inc. K.N.’s immediate family member is an employee of Ono Pharmaceutical. S.H. has a leadership role in iSurgery Ltd. K.O. has a leadership role in M3 AI, Inc. S.H. has consulting and advisory role in M3 Inc. C.K. received honoraria from Takeda, Chugai Pharmaceutical, Bristol-Myers Squibb, MSD, Eisai, Janssen, Sanofi, Astellas Pharma, and Merck KGaA outside of this research. Y.M. received honoraria from Takeda, Ono Pharmaceutical, Bristol-Myers Squibb Japan, MSD, Eisai, Janssen, Taiho Pharmaceutical, Astellas Pharma, and Merck biopharma outside of this research. T.Y., Y.Y., K.T., R.K., T.Y., Y.T., and K.S. declare no competing interests.
